KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Retained Earnings (2018 - 2025)

Historic Retained Earnings for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$1.2 billion.

  • Vir Biotechnology's Retained Earnings fell 7626.02% to -$1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 billion, marking a year-over-year decrease of 7626.02%. This contributed to the annual value of -$759.8 million for FY2024, which is 21947.32% down from last year.
  • Latest data reveals that Vir Biotechnology reported Retained Earnings of -$1.2 billion as of Q3 2025, which was down 7626.02% from -$991.7 million recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Retained Earnings registered a high of $774.3 million during Q2 2021, and its lowest value of -$1.2 billion during Q3 2025.
  • For the 5-year period, Vir Biotechnology's Retained Earnings averaged around -$241.8 million, with its median value being -$237.8 million (2023).
  • Its Retained Earnings has fluctuated over the past 5 years, first skyrocketed by 37217.68% in 2022, then plummeted by 116221.55% in 2024.
  • Vir Biotechnology's Retained Earnings (Quarter) stood at -$138.6 million in 2021, then skyrocketed by 372.18% to $377.2 million in 2022, then plummeted by 163.04% to -$237.8 million in 2023, then crashed by 219.47% to -$759.8 million in 2024, then crashed by 52.0% to -$1.2 billion in 2025.
  • Its last three reported values are -$1.2 billion in Q3 2025, -$991.7 million for Q2 2025, and -$880.7 million during Q1 2025.